Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

about

Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.

P2860

Q33881920-AFE20F07-7AAB-4454-AFB7-32FBE6F8916E Q39358889-1C8FC49F-4D8D-4C4C-9C67-EF21E50427EA

P2860

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

Item

http://www.wikidata.org/entity/Q50977875

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

@en

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

@nl

type

Item

label

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

@en

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

@nl

prefLabel

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

@en

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

@nl

P1476

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

@en

P2093

Nicola Brunetti-Pierri

http://www.w3.org/2001/XMLSchema#string

Pasquale Piccolo

http://www.w3.org/2001/XMLSchema#string

P2860

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector

Coagulation factor X activates innate immunity to human species C adenovirus

Rapid and efficient clearance of blood-borne virus by liver sinusoidal endothelium

Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

The transcription factor IRF3 triggers "defensive suicide" necrosis in response to viral and bacterial pathogens

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

P304

132-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/BIOMEDICINES2020132

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261296735

http://www.w3.org/2001/XMLSchema#string

P698

28548064

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

gene therapy

P932

5423471

http://www.w3.org/2001/XMLSchema#string

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

about

P2860

P2860

Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932